Nobilis Health Corp (HLTH) Downgraded by Zacks Investment Research to “Hold”
Nobilis Health Corp (NYSE:HLTH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.
According to Zacks, “Nobilis Health Corp. own and manage ambulatory and acute care facilities for healthcare services. In addition, it owns and manages ambulatory surgery centers, acute care hospital, imaging centers and urgent care clinic. The company operates primarily in Houston, Dallas and Scottsdale, Arizona. Nobilis Health Corp. is headquartered in Houston, Texas. “
Separately, Canaccord Genuity set a $4.80 price target on Nobilis Health Corp and gave the stock a “buy” rating in a research note on Monday, September 19th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/08/nobilis-health-corp-hlth-downgraded-by-zacks-investment-research-to-hold.html
Nobilis Health Corp (NYSE:HLTH) remained flat at $3.49 on Wednesday. The company’s stock had a trading volume of 146,267 shares. The stock’s 50 day moving average price is $3.41 and its 200-day moving average price is $3.14. Nobilis Health Corp has a 1-year low of $1.82 and a 1-year high of $4.66. The stock has a market cap of $267.97 million and a PE ratio of 5.12.
Nobilis Health Corp (NYSE:HLTH) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.05. The business had revenue of $61.90 million for the quarter, compared to analysts’ expectations of $62.18 million. During the same period in the prior year, the company earned ($0.02) EPS. The company’s revenue for the quarter was up 26.6% compared to the same quarter last year. On average, equities research analysts anticipate that Nobilis Health Corp will post $0.37 earnings per share for the current year.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Rhumbline Advisers raised its position in shares of Nobilis Health Corp by 88.6% in the second quarter. Rhumbline Advisers now owns 44,997 shares of the company’s stock valued at $100,000 after buying an additional 21,135 shares during the period. Geode Capital Management LLC raised its position in shares of Nobilis Health Corp by 10.4% in the first quarter. Geode Capital Management LLC now owns 34,596 shares of the company’s stock valued at $108,000 after buying an additional 3,268 shares during the period. Royal Bank of Canada raised its position in shares of Nobilis Health Corp by 27.1% in the first quarter. Royal Bank of Canada now owns 36,858 shares of the company’s stock valued at $115,000 after buying an additional 7,854 shares during the period. Acadian Asset Management LLC purchased a new position in shares of Nobilis Health Corp during the second quarter valued at $165,000. Finally, Synovus Financial Corp purchased a new position in shares of Nobilis Health Corp during the second quarter valued at $175,000.
About Nobilis Health Corp
Nobilis Health Corp. (Nobilis) owns and manages healthcare facilities in the States of Texas and Arizona, consisting primarily of ambulatory surgery centers (ASCs) and acute-care and surgical hospitals. The Company’s segments include Medical Services, Marketing Services and Corporate. The Medical Services segment owns and manages approximately nine healthcare facilities in Texas and Arizona; over four hospitals, and approximately five ambulatory surgery centers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nobilis Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nobilis Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.